Udder Health Market Size & Share 2025 - 2034

Udder Health Market Size

The global udder health market size was estimated at USD 1.4 billion in 2024. The market is expected to grow from USD 1.5 billion in 2025 to USD 2.5 billion in 2034, at a CAGR of 5.9% during the forecast period. The growth in the market is driven by the increasing concern about mastitis and other udder diseases in dairy animals, as well as the improving diagnostics, therapeutics and preventative measures.

Industry estimates suggest that mastitis has a global prevalence of 20-30% among dairy cows, resulting in substantial economic losses attributed to reduced milk production, treatment costs, and discarded milk. The growing consumption of dairy products requires effective precision in early diagnosis and treatment, as well as preventive measures in veterinary medicine.
 

New minimally invasive treatments, such as intramammary therapy and targeted antibiotic therapy, have gained popularity because they work better, have less chance of causing antimicrobial resistance, and have shorter withdrawal periods. Additionally, there is also improved herd immunity and reduced levels of chronic infections due to novel vaccines, probiotics, and immunomodulators. Further, increasing knowledge among dairy farmers and greater availability of specialized veterinary services are bolstering the market. With ongoing efforts to find novel ways to manage mastitis, which includes genetic selection for disease resistance, the market will continue to grow throughout the forecast period.
 

The market encompasses products, services, and solutions aimed at preventing, diagnosing, and treating udder-related diseases in dairy animals, ensuring milk quality, farm productivity, and overall animal welfare.
 

Udder Health Market Trends

• Growth in the market is driven by the improvement in the diagnostic and therapeutic health care services as well as the increased demand for specialist veterinary services and modern disease control measures.
   
• The rising demand for dairy products plays a crucial role in driving the market. The Organization for Economic Co-operation and Development (OECD) estimates that from 2020 to 2029, nearly 80% of the world's milk production will come from cow milk. This shows the importance of developing advanced solutions to ensure the health and productivity of dairy cows, which are essential for meeting global dairy demands.
   
• Moreover, the need for other treatment options such as probiotics and immunotherapy, or controlled use of antibiotics has greatly increased due to improved resistance to antibiotics and effective mastitis control without compromising milk quality and safety.
   
• Spending on livestock health is another factor that fuels udder health market growth. In 2023, the United States Department of Agriculture (USDA) reported that American dairy producers spent an estimated USD 1.2 billion in prevention and treatment of mastitis.
   
• Increasing prevalence of mastitis which affects 25-30% of cows in any given year, which leads to significant economic loss in different parts of the world. According to the National Institutes of Health (NIH), the total annual economic losses to U.S. dairy farmers due to mastitis are estimated to be between USD 400 and USD 500 million, which equates to approximately USD 23 per cow. This highlights the critical need for better udder health management to minimize the economic burden.
   
• As a result of increased disease prevention efforts, government authorities such as the FDA and EMA have tightened restrictions on antibiotic use, which in turn, has stimulated the need to develop alternative methods for udder treatment. At the same time, the implementation of AI technology in herd monitoring systems is improving early diagnosis and health management of the herd.
   
• Advancements in diagnostic technologies have driven udder health market growth in udder infection management. For example, a July 2023 National Library of Medicine article highlights tools such as PCR, acute phase protein detection, ELISA, and qPCR, which enhance pathogen detection accuracy and specificity, even at the subspecies level. This enables more effective treatment strategies.
   
• Further, government and private sector activities are stimulating the growth of the market. For example, in March 2024, the European Commission funded research directed toward the sustainable health of livestock, including udder disease prevention, with a budget of 15 million Euros.
   
• Similarly, international research organizations such as the International Dairy Federation (IDF) are funding research and development of new diagnostic and therapeutic devices for mastitis and other diseases of the udder. All these activities are likely to promote competition and growth of the economy in the udder health industry during the forecast period.
   

Trump Administration Tariffs

• The tariffs on imports from China, including veterinary diagnostic equipment and electronic components, implemented during the Trump presidency might increase the cost of raw materials and health monitoring devices. These tariffs can also lead to supply chain disruptions, as many udder health solution providers rely heavily on Chinese vendors for affordable diagnostic sensors, RFID tags, and automated milking system parts.
   
• Due to these tariffs, companies operating in the market might have to reevaluate and adjust their sourcing and production strategies to reduce dependency on Chinese suppliers. This might lead to a shift towards sourcing from alternative markets such as India, Vietnam, and Eastern Europe.
   
• Moreover, short-term challenges include delays in product availability, increased operational costs due to vendor diversification, and potential disruptions in after-sales support for diagnostic tools and sensors.
   

Udder Health Market Analysis

Based on product type, the market is segmented into pharmaceutical and supplements. The pharmaceutical segment is further bifurcated into antibiotics, vaccines, anti-inflammatory drugs, teat disinfectants, intramammary infusions, and other pharmaceuticals. The global market was estimated at USD 1.4 billion in 2023. The pharmaceutical segment dominated the market with USD 925.4 million in 2023.
 

• The pharmaceutical segment in the market is growing due to the increasing incidence of mastitis and other udder infections in dairy livestock.
   
• The rising concern over antimicrobial resistance is steering the changes for more precision in the use of antibiotics and alternative solutions such as probiotic based treatments and immune-enhancing formulations.
   
• Regulatory bodies such as the FDA and EMA are becoming stricter on the use of antibiotics, which is stimulating the development of non-antibiotic treatment methods.
   
• Moreover, the implementation of AI controlled prescription systems is increasing the precision of treatments, thereby improving the health of herds and driving growth in the pharmaceutical segment.

Learn more about the key segments shaping this market

Download Free PDF

Based on animal type, the udder health market is divided into dairy cattle, and other animal types. The dairy cattle segment accounted for a significant market share of 85.4% in 2024.
 

• The dairy cattle segment dominates the market, driven by the high economic impact of mastitis which is the leading disease affecting milk production.
   
• With over 270 million dairy cows globally, farmers are investing in preventive healthcare, advanced diagnostics, and precision treatment solutions to maintain herd productivity.
   
• The use of biosensors, AI monitoring systems, and automated milking installations are changing the paradigm of early detection of medical issues. At the same time, use of probiotics and immunotherapy drugs are becoming more accepted because of increased restrictions placed on the use of antimicrobials.
   
• As global dairy demand increases, advancements in genetic selection, nutrition management, and disease-resistant breeding are further enhancing market growth.
   

Based on disease type, the udder health market is divided into mastitis, and other disease types. The mastitis segment is further divided into clinical mastitis and sub-clinical mastitis. The mastitis segment dominated the market in 2024 and is expected to reach USD 1.9 billion by 2034.
 

• The mastitis segment is the largest in the market, as mastitis affects 20-30% of dairy cows globally, causing significant economic losses due to reduced milk yield and quality.
   
• Modern techniques, including those of rapid diagnosis, biosensors, and somatic cell count monitoring are improving early detection.
   
• Antibiotic, probiotics and anti-inflammatory drugs, along with immunomodulators, are the remaining key treatment options while other therapies have started to gain attention due to resistance to microbes.
   
• An increase in investigations into the genetic resistance along with AI-based disease forecasting has further drove the innovation and growth in the market.
   

Based on distribution channel, the udder health market is divided into veterinary hospital pharmacies, retail pharmacies, and other distribution channels. The veterinary hospital pharmacies segment dominated the market in 2024 with USD 649.6 million.      
 

• The veterinary hospital pharmacies segment plays a crucial role in the market, serving as primary distribution channels for diagnostic tools, pharmaceuticals, and preventive care solutions.
   
• Veterinary hospitals provide specialized treatment for mastitis and other udder diseases, utilizing advanced imaging, laboratory diagnostics, and minimally invasive therapies.
   
• Pharmacies distribute antibiotics, anti-inflammatory drugs, vaccines, and probiotics, supporting both clinical treatment and preventive care. With the rising adoption of AI-driven prescription systems and telemedicine services, access to udder health solutions is expanding.
   
• Additionally, government regulations promoting veterinary oversight in drug distribution are driving growth in this segment, ensuring better herd health management.

The North America udder health market held the largest market share of 41% in 2024 in the global market, and it is anticipated to expand at 5.8% CAGR over the forecast period. The U.S. market was valued at USD 516.7 million in 2023.
 

• The market for udder health in the U.S. is growing because of robust dairy industry which has a milk production capacity exceeding 226 billion pounds a year.
   
• There is an increasing demand for sophisticated diagnostic tools, precision treatment and as well as sustainable disease management solutions due to losses associated with mastitis.
   
• The use of automated milking systems combined with video observation of the cows greatly enhances the herd’s productivity and its early detection capabilities.
   
• The decrease of antibiotics use is getting supported from FDA and USDA which in turn is creating a potential boom for probiotics, vaccines, and immune stimulant therapies. Also, enhanced support of dairy research and herd health programs is boosting the market.
   

Europe udder health market accounted for USD 418.8 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The sustained growth of the market in Europe is attributable to the stringent antibiotic regulations and the emphasis placed on sustainable dairy farming practices in the region.
   
• With over 22 million dairy cows, countries such as Germany, France, and the Netherlands are investing in preventive care, genetic selection, and AI-driven monitoring to reduce mastitis cases.
   
• The sustained increase of dairy products without antibiotics is shifting consumer purchasing behavior which increases demand for sustainable udder health products, resulting in innovation in the market. Additionally, EU-funded research programs are advancing precision livestock farming technologies, improving early disease detection.
   
• Rising consumer demand for high-quality, antibiotic-free dairy products is further driving market innovation and the adoption of eco-friendly udder health solutions.
   

The Germany udder health market is experiencing robust growth in Europe market.
 

• Germany's market is expanding, driven by its large dairy industry, with over 3.7 million dairy cows and a strong focus on milk quality and animal welfare.
   
• The country has strict antibiotic regulations, encouraging the adoption of probiotics, vaccines, and precision livestock farming. Government initiatives, such as funding for sustainable dairy farming and antibiotic reduction programs, are further driving innovation.
   
• Additionally, rising consumer demand for organic, antibiotic-free milk products is shaping the future of market in Germany.
   

The Asia Pacific market witnessed substantial growth of 6.2% during the analysis period.
 

• The Asia Pacific market is expanding due to rising dairy consumption, increasing dairy herd sizes, and growing investments in modern farming technologies.
   
• Countries such as China, India, and Australia are adopting advanced mastitis diagnostics, AI-powered monitoring, and automated milking systems to enhance milk quality and yield.
   
• Additionally, rapid urbanization and rising disposable incomes are fueling consumer demand for high-quality dairy products, encouraging farmers to invest in preventive udder health solutions and sustainable disease management practices.
   

The Brazil udder health market is experiencing robust growth in Latin America market.
 

• The udder health industry in Brazil is experiencing growth because of the nation's extensive dairy sector, which is currently among the top five producers of milk in the world with over 16 million dairy cows.
   
• The increasing prevalence of mastitis is driving demand for advanced diagnostics, precision treatments, and disease prevention strategies.
   
• Interest in probiotics, vaccines, and alternative modalities is escalating because of governmental policies aimed at efficient use of antibiotics.
   
• Also, investments in sustainable dairy farming and management of udder health due to increased export market for premium quality dairy products is on the rise.  
   

The Saudi Arabia market is witnessing substantial growth in Middle East and Africa.
 

• The Saudi Arabia market is expanding due to the country's focus on dairy self-sufficiency and the growth of large-scale dairy farms.
   
• Adoption of vaccines, probiotics, and precision livestock management, as well as sustainable dairy farming is being encouraged under the government Vision 2030 initiative, which is also boosting the dairy industry.
   
• Moreover, enhanced expenditure towards veterinary health care facilities, stringent regulations on the quality of milk and the use of antibiotics is further driving market growth.
   

Udder Health Market Share

The top 5 companies in the market, such as Virbac, Boehringer Ingelheim, Zoetis, Ceva Sante Animale, and Merck, accounting for approximately 65% of the market share. These companies maintain their dominance through innovations in diagnostic technologies, antimicrobial treatments, and AI-assisted health management solutions, addressing the rising demand for specialized udder health care. Firms are broadening their portfolios with precision diagnostic tools, automated milking systems, and tailored therapies to improve disease management and treatment accuracy.
 

For example, Zoetis and Merck focus on developing cutting-edge antimicrobial products, while Virbac and Elanco offer comprehensive vaccine solutions. Companies are investing in AI-driven analytics, real-time monitoring systems, and advanced therapeutic interventions, fueling market expansion and intensifying competition in the udder health sector.
 

Udder Health Market Companies

Major players operating in the udder health industry are:

• AHV International
• Albert Kerbl
• Boehringer Ingelheim 
• BouMatic
• Ceva Sante Animale
• DeLaval
• Ecolab
• Elanco Animal Health
• G Shepherd Animal Health
• Merck
• Virbac
• Zoetis
   
• Boehringer Ingelheim offers innovative solutions for udder health, particularly through its comprehensive mastitis management systems. Their Orbenin range of antibiotics provide targeted treatments for udder infections and support lactation health. Leveraging cutting-edge research and a global network, Boehringer Ingelheim's udder health products ensure high efficacy, safety, and veterinary support, enhancing milk quality and farm productivity.
   
• CEVA focuses on providing holistic udder health solutions through its J-VAC mastitis vaccine and Intelligent Dairy management services. CEVA’s advanced vaccine formulations help reduce mastitis incidents, improving overall herd health. Their data-driven approaches optimize milk production while preventing common udder diseases, offering practical and cost-effective solutions to dairy farmers for better herd management.
   
• Zoetis offers a range of udder health solutions, such as Orbeseal and Mastitis Solutions, to ensure effective prevention and treatment of mastitis and other udder-related issues. Their targeted therapies and advanced diagnostic tools help improve overall herd health, milk quality, and farm profitability.
   

Udder Health Industry News

• In August 2023, Zoetis Inc. launched Vetscan Mastigram+, a fast diagnostic tool for detecting mastitis pathogens in dairy cows. This technology enables farmers to swiftly identify infections, minimizing the impact on milk production and enhancing overall udder health management.
   
• In September 2022, Boehringer Ingelheim introduced new susceptibility testing criteria for Ubrolexin, aimed at optimizing its effectiveness in treating mastitis in dairy cows. This update enhances precision in targeting mastitis-causing pathogens, promoting improved treatment outcomes and udder health in dairy herds.
   
• In April 2021, Boehringer Ingelheim expanded its dairy mastitis portfolio by introducing a blue internal teat sealant. This product aims to enhance mastitis prevention and improve udder health by providing an effective barrier against bacterial infections in dairy cows.
   

The udder health market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Pharmaceuticals      
  • Antibiotics
  • Vaccines
  • Anti-inflammatory drugs
  • Teat disinfectants
  • Intramammary infusions
  • Other pharmaceuticals
• Supplements 
  • Vitamins and minerals
  • Probiotics and prebiotics
  • Other supplements

Market, By Animal Type

• Dairy cattle
• Other animal types

Market, By Disease Type

• Mastitis        
  • Clinical mastitis
  • Sub-clinical mastitis
• Other disease types 

Market, By Distribution Channel

• Veterinary hospital pharmacies
• Retail pharmacies
• Other distribution channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE